Publications by authors named "Metodi Stankov"

Claim this Profile
E
Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2.
Lu Zhang, Nianzhen Chen, Amy Eichmann, Inga Nehlmeier, Anna-Sophie Moldenhauer, Metodi V Stankov

Lancet Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of JN.1 and KP.2 COVID-19 mRNA vaccines against emerging SARS-CoV-2 variants.
Ninaad Lasrado, Annika Rössler, Isabella McConnell, Katherine Molloy, Ritobhas Bhowmik, Metodi V Stankov

Vaccine· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of LP.8.1-adapted mRNA vaccination on SARS-CoV-2 variant neutralisation.
Christine Happle, Markus Hoffmann, Metodi V Stankov, Inga Nehlmeier, Amy Eichmann

Lancet Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2.
Lu Zhang, Amy Kempf, Inga Nehlmeier, Nianzhen Chen, Metodi V Stankov

Lancet Microbe· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant.
Lu Zhang, Amy Kempf, Inga Nehlmeier, Nianzhen Chen, Luise Graichen, Metodi V Stankov

Virology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral Immune Responses in Dialysis Patients After mRNA Omicron JN.1 Vaccination.
Metodi V Stankov, Markus Hoffmann, Christine Happle, Karsten Lürken, Amy Kempf

Kidney Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1.
Lu Zhang, Amy Kempf, Inga Nehlmeier, Nianzhen Chen, Metodi V Stankov

Lancet Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease.
Karsten Lürken, Anna Meinecke, Luis A Manthey, Anne Cossmann, Metodi V Stankov

Eur J Med Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera.
Najat Bdeir, Tatjana Lüddecke, Henrike Maaß, Stefan Schmelz, Ulfert Rand, Metodi V Stankov

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC.
Prerna Arora, Christine Happle, Amy Kempf, Inga Nehlmeier, Metodi V Stankov

Lancet Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients.
Philippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann, Alexandra Linke, Inga Nehlmeier, Metodi Stankov

Viruses· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination.
Christine Happle, Markus Hoffmann, Amy Kempf, Inga Nehlmeier, Metodi V Stankov

Lancet Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization.
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, Bojan Hörnich, Luise Graichen, Metodi V Stankov

PLoS Pathog· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1.
Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, Amy Kempf, Inga Nehlmeier, Metodi V Stankov

Vaccines (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion.
Lu Zhang, Alexandra Dopfer-Jablonka, Anne Cossmann, Metodi V Stankov, Luise Graichen

iScience· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage.
Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier, Amy Kempf, Luise Graichen, Metodi V Stankov

Vaccines (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany.
Anne Cossmann, Markus Hoffmann, Metodi V Stankov, Karsten Lürken, Gema Morillas Ramos

Lancet Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Lu Zhang, Amy Kempf, Inga Nehlmeier, Anne Cossmann, Anja Richter, Metodi V Stankov

Cell· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.
Metodi V Stankov, Markus Hoffmann, Rodrigo Gutierrez Jauregui, Anne Cossmann, Gema Morillas Ramos

Lancet Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.
Ivan Odak, Lennart Riemann, Inga Sandrock, Anne Cossmann, Gema Morillas Ramos, Metodi V Stankov

EBioMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3.
Lu Zhang, Amy Kempf, Inga Nehlmeier, Anne Cossmann, Alexandra Dopfer-Jablonka, Metodi V Stankov

Lancet Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage.
Inga Nehlmeier, Amy Kempf, Prerna Arora, Anne Cossmann, Alexandra Dopfer-Jablonka, Metodi V Stankov

Cell Mol Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.
Joana Barros-Martins, Swantje I Hammerschmidt, Gema Morillas Ramos, Anne Cossmann, Laura Hetzel, Metodi V Stankov

Front Immunol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage.
Prerna Arora, Anne Cossmann, Sebastian R Schulz, Gema Morillas Ramos, Metodi V Stankov

Lancet Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death.
Harshit Shah, Metodi Stankov, Diana Panayotova-Dimitrova, Amir Yazdi, Ramachandramouli Budida

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis